Multi-center OPT study funded

Great news: our Impact Explorer grant has been awarded.

With this funding, we will launch a multi-center study across leading European ocular proton therapy centers: HollandPTC, PSI, Clatterbridge, Berlin, WPE, MedAustron, and Nice. Together, we will compare treatment planning strategies and evaluate the impact of image-based target definition.

For a rare disease such as uveal melanoma, international collaboration is essential to move the field forward. We are looking forward to starting this work with colleagues across Europe and to meeting many of you next week at the PTCOG conference. You can find an overview of our presentations here.